Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Papular xanthoma is a form of non-Langerhans cell histiocytosis characterized by cutaneous presentation of solitary or disseminated yellow to orange-brown papular or papulonodular, noncoalescent, asymptomatic skin lesions located predominantly on the head, neck, trunk and extremities (rarely on oral mucosa), in the presence of normolipidemia. Microscopically, the lesions consist of monomorphous infiltrate of xanthomatized macrophages and numerous Touton giant cells, with scant or absent inflammatory infiltrate. It is usually not associated with systemic disease.
No clinical trials have been registered for papular xanthoma.
2 publications have been identified in PubMed for papular xanthoma. Research spans Review / Meta-Analysis (50%) and Case Report / Case Series (50%).
Selvaraj S (2025). [PMID: 40589692](https://pubmed.ncbi.nlm.nih.gov/40589692/). *Cureus*. [Case Report / Case Series]
Ortonne N (2024). [PMID: 39368935](https://pubmed.ncbi.nlm.nih.gov/39368935/). *Ann Pathol*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:54 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center